Metraipolis › archive › dc_72c2f1cdefd2

Value of Annual MRI Monitoring in Patients With Multiple Sclerosis Treated With Ocrelizumab: A Number Needed to Scan Analysis — Europe PMC PMID:42525900

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42525900
DOI
10.1212/wnl.0000000000218379
License (as archived)
solo-consultazione
Archived
2026-10-17T10:50:27.178Z
SHA-256 of the archived text
3e1bfbf2c7bf4351778fedbb406d3f06857764115900fcb1e730e24b3d4d1abb
Stable URL of this page
https://metraipolis.com/documento/dc_72c2f1cdefd2

How to cite

Value of Annual MRI Monitoring in Patients With Multiple Sclerosis Treated With Ocrelizumab: A Number Needed to Scan Analysis — Europe PMC PMID:42525900 — Europe PMC (en), https://europepmc.org/article/MED/42525900 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_72c2f1cdefd2 (Metraipolis archive dc_72c2f1cdefd2, sha256 3e1bfbf2c7bf4351778fedbb406d3f06857764115900fcb1e730e24b3d4d1abb)
BibTeX
@misc{dc72c2f1cdefd2,
  title = {Value of Annual MRI Monitoring in Patients With Multiple Sclerosis Treated With Ocrelizumab: A Number Needed to Scan Analysis — Europe PMC PMID:42525900},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42525900},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_72c2f1cdefd2; sha256 3e1bfbf2c7bf4351778fedbb406d3f06857764115900fcb1e730e24b3d4d1abb},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42525900. Agents can read the archived copy with the MCP tool read_document.